Ginkgo biloba is a plant of the Ginkgo genus of Ginkgoaceae, which is a traditional medicinal material in China and has a high frequency of clinical application. The main chemical components of Ginkgo biloba are flavonoids, terpenoids, alkylphenols (acids), polysaccharides and other trace elements. In terms of pharmacological effects, Ginkgo biloba has been found to have anti-inflammatory, anti-oxidant, anti-tumor, neuroprotective, anti-depressant and other effects, and have broad prospects in the treatment of nervous system diseases, anti-tumor, anti-depression and so on. This article reviews the herbal textual research, chemical components and pharmacological effects of Ginkgo biloba, in order to provide references for the clinical application and comprehensive utilization of resources.
1.Hassan I, Wan ibrahim WN, Yusuf FM, et al. Biochemical constituent of Ginkgo biloba (seed) 80% methanol extract inhibits cholinesterase enzymes in javanese medaka (Oryzias javanicus) model[J]. J Toxicol, 2020, 2020: 8815313. DOI: 10.1155/2020/8815313.
2.唐德才, 吴庆光, 主编. 中药学. 第3版[M]. 人民卫生出版社. 2016: 272.
3.中国药典2020年版.一部[S]. 2020: 499.
4.孟杰, 王国霖, 陆宜斌, 等. 银杏叶药效分子机制研究进展 [J]. 药学研究, 2023, 42(8): 588-593, 635. [Meng J, Wang GL, Lu YB, et al. Research progress on the pharmacological mechanism of Ginkgo biloba leaves[J]. Journal of Pharmaceutical Research, 2023, 42(8): 588-593, 635.] DOI: 10.13506/j.cnki.jpr.2023.08.010.
5.Liu Y, Xin H, Zhang Y, et al. Leaves, seeds and exocarp of Ginkgo biloba L. (Ginkgoaceae): a comprehensive review of traditional uses, phytochemistry, pharmacology, resource utilization and toxicity[J]. J Ethnopharmacol, 2022, 298: 115645. DOI: 10.1016/j.jep.2022.115645.
6.Hui W, Huang W, Zheng Z, et al. Ginkgo biloba extract promotes Treg differentiation to ameliorate ischemic stroke via inhibition of HIF-1α/HK2 pathway[J]. Phytother Res, 2023, 37(12): 5821-5836. DOI: 10.1002/ptr.7988.
7.Gachowska M, Szlasa W, Saczko J, et al. Neuroregulatory role of ginkgolides[J]. Mol Biol Rep, 2021, 48(7): 5689-5697. DOI: 10.1007/s11033-021-06535-2.
8.Abdel-emam RA, Abd-eldayem AM. Systemic and topical Ginkgo biloba leaf extract (Egb-761) ameliorated rat paw inflammation in comparison to dexamethasone[J]. Ethnopharmacol, 2022, 282: 114619. DOI: 10.1016/j.jep.2021.114619.
9.南宋·王继先, 著. 尚志钧, 校注. 绍兴本草校注[M]. 北京: 中国古籍出版社, 2007: 344.
10.明·李时珍, 著. 《本草纲目》新校注本[M]. 北京: 华夏出版社, 2008: 1209-1210.
11.明·陈嘉谟, 著. 本草蒙筌[M]. 北京: 中国中医药出版社, 2013: 197.
12.Liu L, Wang Y, Zhang J, et al. Advances in the chemical constituents and chemical analysis of Ginkgo biloba leaf, extract, and phytopharmaceuticals[J]. J Pharm Biomed Anal, 2021, 193: 113704. DOI: 10.1016/j.jpba.2020.113704.
13.冯靖, 彭效明, 李翠清, 等. 银杏叶黄酮的抗氧化性及其稳定性研究[J]. 食品科技, 2019, 44(4): 244-249. [Feng J, Peng XM, Li CQ, et al. Antioxidant activity and stability of flavonoids from ginkgo leaves[J]. Food Science and Technology, 2019, 44(4): 244-249.] DOI: 10.13684/j.cnki.spkj.2019.04.044.
14.Biernacka P, Adamska I, Felisiak K. The potential of ginkgo biloba as a source of biologically active compounds-a review of the recent literature and patents[J]. Molecules, 2023, 28(10): 3993. DOI: 10.3390/molecules28103993.
15.罗小芳, 覃佐东, 袁琦韵, 等. 简析银杏研究的相关进展[J]. 科技通报, 2016, 32(8): 36-40, 45. [Luo XF, Tan ZD, Yuan QY, et al. related research progress of Ginkgo biloba[J]. Bulletin of Science and Technology, 2016, 32(8): 36-40, 45.] DOI: 10.13774/j.cnki.kjtb.2016.08.009.
16.Ji S, He DD, Wang TY, et al. Separation and characterization of chemical constituents in Ginkgo biloba extract by off-line hydrophilic interaction×reversed-phase two-dimensional liquid chromatography coupled with quadrupole-time of flight mass spectrometry[J]. J Pharm Biomed Anal, 2017, 146: 68-78. DOI: 10.1016/j.jpba.2017.07.057.
17.Shu P, Fei Y, Li J, et al. Two new phenylethanoid glycosides from Ginkgo biloba leaves and their tyrosinase inhibitory activities[J]. Carbohydr Res, 2020, 494: 108059. DOI: 10.1016/j.carres.2020.108059.
18.Shu P, Sun M, Li J, et al. Chemical constituents from Ginkgo biloba leaves and their cytotoxicity activity[J]. J Nat Med, 2020, 74(1): 269-274. DOI: 10.1007/s11418-019-01359-8.
19.Chen X, Zhong W, Shu C, et al. Comparative analysis of chemical constituents and bioactivities of the extracts from leaves, seed coats and embryoids of Ginkgo biloba L[J]. Nat Prod Res, 2021, 35(23): 5498-5501. DOI: 10.1080/14786419.2020.1788020.
20.陶叶琴, 熊丹, 王鑫, 等. 基于UPLC-Q-TOF-MS技术的银星养脑方化学成分分析[J]. 中国医院药学杂志, 2024, 44(18): 2090-2094. [Tao YQ, Xiong D, Wang X, et al. Identification of chemical constituents in Yinxing Yangnao Prescription by UPLC-Q-TOF-MS[J]. Chinese Journal of Hospital Pharmacy, 2024, 44(18): 2090-2094.] DOI: 10.13286/j.1001-5213.2024.18.03.
21.Dong HL, Lin S, Wu QL, et al. A new bilobalide isomer and two cis-coumaroylated flavonol glycosides from Ginkgo biloba leaves[J]. Fitoterapia, 2020, 142: 104516. DOI: 10.1016/j.fitote.2020.104516.
22.Noor-E-Tabassum, Das R, Lami MS, et al. Ginkgo biloba: a treasure of functional phytochemicals with multimedicinal applications[J]. Evid Based Complement Alternat Med, 2022, 2022: 8288818. DOI: 10.1155/2022/8288818.
23.van Beek TA, Wintermans MS. Preparative isolation and dual column high-performance liquid chromatography of ginkgolic acids from Ginkgo biloba[J]. J Chromatogr A, 2001, 930(1-2): 109-117. DOI: 10.1016/s0021-9673(01)01194-3.
24.孙芳, 王璐, 闫滨, 等. 银杏叶提取物活性成分及其药理作用[J]. 山东中医杂志, 2014, 33(3): 221-223. [Sun F, Wang L, Yan B, et al. Chemical components and pharmacological effects of ginkgo biloba extracts[J]. Shandong Journal of Traditional Chinese Medicine, 2014, 33(3): 221-223.] DOI: 10.16295/j.cnki.0257-358x.2014.03.036.
25.张红梅. 天然药物银杏的化学成分和药理作用[J].首都师范大学学报(自然科学版), 2014, 35(3): 41-46, 66. [Zhang HM. Chemical composition and pharmacological effects of the natural medicine Ginkgo biloba[J]. Journal of Capital Normal University (Natural Sciences Edition), 2014, 35(3): 41-46, 66.] DOI: 10.19789/j.1004-9398.2014.03.009.
26.Kato-noguchi H, Takeshita S, Kimura F, et al. A novel substance with allelopathic activity in Ginkgo biloba[J]. J Plant Physiol, 2013, 170(18): 1595-1599. DOI: 10.1016/j.jplph.2013.07.003.
27.Ye J, Ye C, Huang Y, et al. Ginkgo biloba sarcotesta polysaccharide inhibits inflammatory responses through suppressing both NF-κB and MAPK signaling pathway[J]. J Sci Food Agric, 2019, 99(5): 2329-2339. DOI: 10.1002/jsfa.9431.
28.Fang J, Wang Z, Wang P, et al. Extraction, structure and bioactivities of the polysaccharides from Ginkgo biloba: a review[J]. Int J Biol Macromol, 2020, 162: 1897-1905. DOI: 10.1016/j.ijbiomac.2020.08.141.
29.Yang JF, Zhou DY, Liang ZY. A new polysaccharide from leaf of Ginkgo biloba L[J]. Fitoterapia, 2009, 80(1): 43-47. DOI: 10.1016/j.fitote.2008.09.012.
30.Yuan F, Yu R, Yin Y, et al. Structure characterization and antioxidant activity of a novel polysaccharide isolated from Ginkgo biloba[J]. Int J Biol Macromol, 2010, 46(4): 436-439. DOI: 10.1016/j.ijbiomac.2010.02.002.
31.Ren Q, Chen J, Ding Y, et al. In vitro antioxidant and immunostimulating activities of polysaccharides from Ginkgo biloba leaves[J]. Int J Biol Macromol, 2019, 124: 972-980. DOI: 10.1016/j.ijbiomac.2018.11.276.
32.Abdel-latif HMR, Hendam BM, Nofal MI, et al. Ginkgo biloba leaf extract improves growth, intestinal histomorphometry, immunity, antioxidant status and modulates transcription of cytokine genes in hapa-reared Oreochromis niloticus[J]. Fish Shellfish Immunol, 2021, 117: 339-349. DOI: 10.1016/j.fsi.2021.06.003.
33.Machado MMF, Banin RM, Thomaz FM, et al. Ginkgo biloba extract (GbE) restores serotonin and leptin receptor levels and plays an antioxidative role in the hippocampus of ovariectomized rats[J]. Mol Neurobiol, 2021, 58(6): 2692-2703. DOI: 10.1007/s12035-021-02281-5.
34.Silva AM, Silva SC, Soares JP, et al. Ginkgo biloba l. leaf extract protects HepG2 cells against paraquat-induced oxidative DNA damage[J]. Plants (Basel), 2019, 8(12): 556. DOI: 10.3390/plants8120556.
35.赵浩晨, 王婉婷, 雷佳美,等. 银杏果外种皮多糖的脱色工艺及抗氧化活性研究[J]. 江苏农业科学, 2020, 48(10): 228-231. [Zhao HC, Wang WT, Lei JM, et al. Study on decolorization process and antioxidant activity of ginkgo fruit exocarp polysaccharide[J]. Jiangsu Agricultural Sciences, 2020, 48(10): 228-231.] DOI: 10.15889/j.issn.1002-1302.2020.10.042.
36.Cao J, Chen L, Li M, et al. Efficient extraction of proanthocyanidin from Ginkgo biloba leaves employing rationally designed deep eutectic solvent-water mixture and evaluation of the antioxidant activity[J]. J Pharm Biomed Anal, 2018, 158: 317-326. DOI: 10.1016/j.jpba.2018.06.007.
37.Fadoul G, Ikonomovic M, Zhang F, et al. The cell-specific roles of Nrf2 in acute and chronic phases of ischemic stroke[J]. CNS Neurosci Ther, 2024, 30(3): e14462. DOI: 10.1111/cns.14462.
38.Liu Q, Jin Z, Xu Z, et al. Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo[J]. Cell Stress Chaperones, 2019, 24(2): 441-452. DOI: 10.1007/s12192-019-00977-1.
39.Song W, Zhao J, Yan XS, et al. Mechanisms Associated with protective effects of ginkgo biloba leaf extracton in rat cerebral ischemia reperfusion injury[J]. J Toxicol Environ Health A, 2019, 82(19): 1045-1051. DOI: 10.1080/15287394.2019.1686215.
40.Trejo-lopez JA, Yachnis AT, Prokop S. Neuropathology of alzheimer's disease[J]. Neurotherapeutics, 2022, 19(1): 173-185. DOI: 10.1007/s13311-021-01146-y.
41.Batawi AH. Ginkgo biloba extract mitigates the neurotoxicity of AlCl3 in alzheimer rat's model: role of apolipoprotein E4 and clusterin genes in stimulating ROS generation and apoptosis[J]. Int J Neurosci, 2024, 134(1): 34-44. DOI: 10.1080/00207454.2022.2082968.
42.Wang J, Zhuang L, Ding Y, et al. A RNA-seq approach for exploring the protective effect of ginkgolide B on glutamate-induced astrocytes injury[J]. J Ethnopharmacol, 2021, 270: 113807. DOI: 10.1016/j.jep.2021.113807.
43.Kalia LV, Lang AE. Parkinson's disease[J]. Lancet, 2015, 386(9996): 896-912. DOI: 10.1016/S0140-6736(14)61393-3.
44.Adebayo OG, Asiwe JN, Ben-azu B, et al. Ginkgo biloba protects striatal neurodegeneration and gut phagoinflammatory damage in rotenone-induced mice model of Parkinson's disease: role of executioner caspase-3/Nrf2/ARE signaling[J]. J Food Biochem, 2022, 46(9): e14253. DOI: 10.1111/jfbc.14253.
45.Kuang S, Yang L, Rao Z, et al. Effects of ginkgo biloba extract on a53t α-synuclein transgenic mouse models of parkinson's disease[J]. Can J Neurol Sci, 2018, 45(2): 182-187. DOI: 10.1017/cjn.2017.268.
46.Yang X, Zheng T, Hong H, et al. Neuroprotective effects of Ginkgo biloba extract and Ginkgolide B against oxygen-glucose deprivation/reoxygenation and glucose injury in a new in vitro multicellular network model[J]. Front Med, 2018, 12(3): 307-318. DOI: 10.1007/s11684-017-0547-2.
47.Kumari P, Wadhwa M, Chauhan G, et al. Hypobaric hypoxia induced fear and extinction memory impairment and effect of Ginkgo biloba in its amelioration: behavioral, neurochemical and molecular correlates[J]. Behav Brain Res, 2020, 387: 112595. DOI: 10.1016/j.bbr.2020.112595.
48.Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024, 74(3): 229-263. DOI: 10.3322/caac.21834.
49.Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249. DOI: 10.3322/caac.21660.
50.Almatroudi A, Allemailem KS, Alwanian WM, et al. Effects and mechanisms of kaempferol in the management of cancers through modulation of inflammation and signal transduction pathways[J]. Int J Mol Sci, 2023, 24(10): 8630. DOI: 10.3390/ijms24108630.
51.Zonouz AM, Rahbardar MG, Hosseinzadeh H. The molecular mechanisms of ginkgo (Ginkgo biloba) activity in signaling pathways: a comprehensive review[J]. Phytomedicine, 2024, 126: 155352. DOI: 10.1016/j.phymed.2024.155352.
52.Ahmed HH, Shousha WG, El-mezayen HA, et al. Biochemical and molecular evidences for the antitumor potential of Ginkgo biloba leaves extract in rodents[J]. Acta Biochim Pol, 2017, 64(1): 25-33. DOI: 10.18388/abp.2015_1200.
53.Fu Z, Lin L, Liu S, et al. Ginkgo biloba extract inhibits metastasis and ERK/Nuclear factor kappa B (NF-κB) signaling pathway in gastric cancer[J]. Med Sci Monit, 2019, 25: 6836-6845. DOI: 10.12659/MSM.915146.
54.俞赟丰, 唐佩, 周曼丽, 等. 基于“正虚邪滞”理论探讨肺癌自噬机制及中药干预进展[J]. 中国实验方剂学杂志, 2023, 29(18): 190-197. [Yu YF, Tang P, Zhou ML, et al. Chinese medicine intervention on autophagy in lung cancer from theory of healthy Qi deficiency and pathogenic Qi stagnation: a review[J]. Chinese Journal of Experimental Traditional Medical Formulae, 2023, 29(18): 190-197.] DOI: 10.13422/j.cnki.syfjx.202202227.
55.Wang X, Shao QH, Zhou H, et al. Retraction note: ginkgolide b inhibits lung cancer cells promotion via beclin-1-dependent autophagy[J]. BMC Complement Med Ther, 2023, 23(1): 251. DOI: 10.1186/s12906-023-04095-5.
56.Lou JS, Zhao LP, Huang ZH, et al. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer[J]. Phytomedicine, 2021, 80: 153370. DOI: 10.1016/j.phymed.2020.153370.
57.Hu WH, Chan GKL, Duan R, et al. Synergy of ginkgetin and resveratrol in suppressing VEGF-induced angiogenesis: a therapy in treating colorectal cancer[J]. Cancers (Basel), 2019, 11(12): 1828. DOI: 10.3390/cancers11121828.
58.Liu L, Wang H, Chen X,et al. Gut microbiota and its metabolites in depression: from pathogenesis to treatment[J]. EBioMedicine, 2023, 90: 104527. DOI: 10.1016/j.ebiom.2023.104527.
59.Rikhani K, Vas C, Jha MK. Approach to diagnosis and management of treatment-resistant depression[J]. Psychiatr Clin North Am, 2023, 46(2): 247-259. DOI: 10.1016/j.psc.2023.02.011.
60.König H, König HH, Konnopka A. The excess costs of depression: a systematic review and meta-analysis[J]. Epidemiol Psychiatr Sci, 2019, 29: e30. DOI: 10.1017/S2045796019000180.
61.邵智星, 李燕青, 袁博博, 等. 银杏达莫注射液联合氟哌噻吨美利曲辛治疗脑卒中后抑郁患者的随访研究[J]. 山西医药杂志, 2020, 49(17): 2316-2318. [Shao ZX, Li YQ, Yuan BB, et al. Follow-up study of ginkgo biloba and dipyridamole injection combined with flupentixol melitracen in the treatment of patients with post-stroke depression[J]. Shanxi Medical Journal, 2020, 49(17): 2316-2318.] DOI: 10.3969/j.issn.0253-9926.2020.17.025.
62.Dai CX, Hu CC, Shang YS, et al. Role of Ginkgo biloba extract as an adjunctive treatment of elderly patients with depression and on the expression of serum S100B[J]. Medicine (Baltimore), 2018, 97(39): e12421. DOI: 10.1097/MD.0000000000012421.
63.黄徐胜. 分子印迹固相萃取分离纯化白果内酯及抗抑郁作用研究[D]. 合肥: 合肥工业大学, 2021. DOI: 10.27101/d.cnki.ghfgu.2021.001537.
64.张学丽, 蔡晓莹, 厉伟兰, 等. 银杏叶提取物对慢性社交挫败应激小鼠外周血清代谢物的调控作用[J]. 中国药学杂志, 2021, 56(7): 546-552. [Zhang XL, Cai XY, Li WL, et al. Regulatory effects of ginkgo biloba extract on peripheral serum metabolite profile of mice with depression-like behavior[J].Chinese Pharmaceutical Journal, 2021, 56(7): 546-552.] DOI: 10.11669/cpj.2021.07.006.
65.Chen P, Hei M, Kong L, et al. One water-soluble polysaccharide from Ginkgo biloba leaves with antidepressant activities via modulation of the gut microbiome[J]. Food Funct, 2019, 10(12): 8161-8171. DOI: 10.1039/c9fo01178a.
66.Tian J, Popal MS, Liu Y, et al. Erratum to "ginkgo biloba leaf extract attenuates atherosclerosis in streptozotocin-induced diabetic apoE-/- mice by inhibiting endoplasmic reticulum stress via restoration of autophagy through the mtor signaling pathway"[J]. Oxid Med Cell Longev, 2019, 2019: 3084083. DOI: 10.1155/2019/3084083.
67.Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045[J]. Diabetes Res Clin Pract, 2022, 183: 109119. DOI: 10.1016/j.diabres.2021.109119.
68.Moreno JA, Gomez-guerrero C, Mas S, et al. Targeting inflammation in diabetic nephropathy: a tale of hope[J]. Expert Opin Investig Drugs, 2018, 27(11): 917-930. DOI: 10.1080/13543784.2018.1538352.
69.Wei L, Jian P, Erjiong H, et al. Ginkgetin alleviates high glucose-evoked mesangial cell oxidative stress injury, inflammation, and extracellular matrix (ECM) deposition in an AMPK/mTOR-mediated autophagy axis[J]. Chem Biol Drug Des, 2021, 98(4): 620-630. DOI: 10.1111/cbdd.13915.